CVE-2026-21970
Official description Straight from the sourceThe vendor's or NVD's own wording, published unedited. Authoritative, but often terse — it says what broke, rarely what to do.
NVD · uneditedVulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).
Technical summary Written by usOur analysis, written from the advisory, the CVSS vector and the affected-version data. It adds context the advisory leaves out, and never invents facts that are not in the source.
dbcve analysis · high confidenceWeb-based authorization vulnerability in Oracle Life Sciences Central Designer platform component allows low-privileged authenticated attackers via HTTP to access sensitive data beyond their authorized scope. The CVSS vector indicates a network-exploitable, low-complexity attack with high confidentiality impact but no integrity or availability impact.
Verify against the referenced sources before acting — the references below are authoritative for this CVE, this summary is not.
Affected products & versions What the vendor confirmedThe version ranges the vendor confirmed as vulnerable. If your version sits inside a range here, treat yourself as exposed until you have upgraded.
NVD · CPE data= 7.0.1.0CVSS breakdown How the score is builtThe industry scoring standard. It rates how the flaw is reached, what it takes to exploit, and what an attacker gains — the score is derived from those, not the other way round.
From the vector- Attack vector
- Network
- Complexity
- Low
- Privileges
- Low
- User interaction
- None
- Scope
- Unchanged
- Confidentiality
- High
- Integrity
- None
- Availability
- None
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
Am I affected? How to checkSteps we derive from the advisory and the affected-version data, so you can decide whether this CVE reaches your setup. They are a guide, not a scan — your own configuration is the authority.
dbcve checksWork through these to decide whether this CVE applies to you.
-
Identify installed Oracle Life Sciences Central Designer versionLocate the Central Designer installation directory and check the version manifest, about page, or version file within the product. Alternatively, query the Oracle database for product version tables if accessible through Central Designer administrative interfaces.Affected if The installed version is exactly 7.0.1.0
-
Verify web interface is enabled and accessibleConfirm that the Central Designer web component (HTTP/HTTPS listener) is running and reachable on the network. Check if the application responds to requests on typical web ports.Affected if The web interface is exposed and responds to HTTP/HTTPS requests
-
Confirm authentication is configuredVerify that user authentication is enabled in Central Designer and that low-privileged user accounts exist within the system.Affected if Low-privileged authenticated users can log in to the platform
-
Check authorization boundariesReview user role assignments and data access permissions within Central Designer to understand the defined authorization scope for different user roles.Affected if Users with limited roles can potentially access data outside their assigned scope through the web interface
A user is affected if they are running exactly version 7.0.1.0 of Oracle Life Sciences Central Designer with its web interface accessible and low-privileged accounts configured, allowing unauthorized data access beyond role permissions.
Generated from the published advisory. Verify against your own configuration.
Remediation Closing itWhat it takes to close this. Where a vendor fix exists we point at it; where none exists we say so plainly, and can build one. Effort estimates are scoped from the advisory, not from your codebase.
From vendor dataApply Oracle's security patch for version 7.0.1.0 when available. Implement network segmentation, restrict HTTP/HTTPS access to trusted IPs, and deploy WAF rules as interim controls.
- Consultation2.0 h
- Implementation4.0 h
- Testing6.0 h
- Review / QA3.0 h
An estimate, not a bill — we confirm scope with you before any work starts. Need it this week? Rush from $4,096.
Scan for this in your stack
Free · runs locallyCheck whether your project pulls in CVE-2026-21970 — or any other known-vulnerable package — straight from your lock files. Free and open source; it runs locally and uploads nothing.
References Go to the primary sourcePrimary sources — vendor advisories, patches and trackers. Where our summary and a reference disagree, the reference wins.
Primary sourcesPractitioner notes
ContributedPeer-ranked notes from engineers who’ve handled CVE-2026-21970 in production — separate from our analysis above.
The advisory tells you what broke. It rarely tells you what actually worked. If you’ve dealt with this one, that detail is what the next engineer is searching for.
- The version that genuinely resolved it — not the one the vendor claimed
- A config change or rule that shut the vector down
- A gotcha in the upgrade path that cost you an afternoon
No notes yet
Be the first to add a field note for this CVE — a mitigation you’ve verified, a version caveat, or a link to a working fix. Sign in above to contribute.
A place for practitioners to share what actually worked: a mitigation you’ve tested, a configuration change, a version- or environment-specific caveat, or a link to a verified patch. The most useful notes rise to the top as peers upvote them, so the signal stays high.
- Verified mitigations, workarounds, and config changes
- Version or environment caveats, and links to real fixes
- No weaponised exploit code, or anything meant to cause harm
- No spam, self-promotion, credentials, or personal data